# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-28T21:43:13.925284
**Response ID:** resp_051b2b970696494400697a7420685c81978d6302c9754c5ad8
**Tokens:** 4448 in / 4658 out
**Response SHA256:** 32e4615897d9d973

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

- **Treatment timing vs. data coverage:** Your stated sample is **2012–2021** (CBP establishments; 510 state-year obs). All treatment variation described (states exceeding the federal $7.25 at some point **by 2021**) is **within the data window**. No instance of “treated after sample ends.”
- **Post-treatment observations:** For staggered adopters, the design mechanically provides post-treatment years for early/mid adopters; late adopters (e.g., 2020/2021) will have fewer post years but still at least some post data in-sample. No cohort is described as treated with *zero* post-treatment observations.
- **Treatment definition consistency:** The paper consistently uses two treatment concepts:
  - a **continuous** treatment in TWFE: `log(real MW)`
  - a **binary** treatment: “Above Federal”
  and the event study / C&S analysis is explicitly tied to **crossing above the federal floor**, with **already-above-federal in 2012 excluded**. The cohort counts are internally consistent (29 ever-above = 13 already-above in 2012 + 16 within-sample adopters; plus 22 never-treated = 51).

**No fatal data–design misalignment detected.**

---

## 2) REGRESSION SANITY (CRITICAL)

Checked **Table 2** and **Table 3**:

- Coefficients on log outcomes are small (order 0.01) and not implausible.
- Standard errors are of reasonable magnitude; none are extreme or indicative of mechanical collinearity artifacts (no “exploding SEs,” no SEs orders of magnitude larger than coefficients in a way that screams a broken regression).
- No impossible outputs (no NA/NaN/Inf; no negative SEs; no impossible R² reported).

**No fatal regression sanity issues detected.**

---

## 3) COMPLETENESS (CRITICAL)

- Regression tables report **N** and **SEs** (Tables 2–3).
- No placeholders (“TBD/TODO/XXX/NA”) appear in the excerpted tables/figures.
- The paper references Table 1–3 and Figure 1, and each is present in the provided draft excerpt (no dangling references in what you shared).

**No fatal completeness issues detected.**

---

## 4) INTERNAL CONSISTENCY (CRITICAL)

- Key numeric claims match the displayed estimates:
  - Elasticity **−0.018 (SE 0.036)** in Table 2 is used consistently in text/abstract.
  - The implied effect for a 10% increase (≈ **−0.18%**) is arithmetically consistent with a log-log elasticity.
  - The reported C&S ATT **−0.013 (SE 0.012)** is consistent with the stated CI.
- Sample accounting is consistent across sections (510 obs overall; C&S sample excludes 13 already-treated in 2012, leaving 38 = 22 never + 16 adopters).

**No fatal internal inconsistencies detected.**

---

ADVISOR VERDICT: PASS